fluconazole has been researched along with nystatin a1 in 155 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 34 (21.94) | 18.2507 |
| 2000's | 49 (31.61) | 29.6817 |
| 2010's | 61 (39.35) | 24.3611 |
| 2020's | 11 (7.10) | 2.80 |
| Authors | Studies |
|---|---|
| Chaturvedi, AK; Shukla, PK; Tandon, VK; Yadav, DB | 1 |
| Chaturvedi, AK; Shukla, PK; Singh, RV; Tandon, VK; Yadav, DB | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
| Fritsche, TR; Jones, RN; Rhomberg, PR; Sader, HS | 1 |
| Bergès, T; Bouchara, JP; Chabasse, D; Ernoult, E; Larcher, G; Tronchin, G; Vandeputte, P | 1 |
| Maurya, HK; Panda, D; ShivaKeshava, GB; Shukla, PK; Srivastava, P; Tandon, VK; Tripathi, A | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Maurya, HK; Mishra, NN; Shukla, PK; Tandon, VK | 2 |
| Kumar, R; Maurya, HK; Shukla, PK; Tandon, VK; Verma, MK | 1 |
| el-Torgman, AA; Hawata, MA; Hilmy, KM; Keshk, RM; Khalifa, MM | 1 |
| Dolezal, M; Jilek, P; Kucera, R; Kunes, J; Svobodova, M; Vejsova, M; Zitko, J | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Janiszewska, J; Milewski, S; Rajnisz, A; Solecka, J; Sowińska, M; Urbańczyk-Lipkowska, Z; Łącka, I | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ; Teraiya, SB | 1 |
| Barad, HA; Gupta, VK; Kant, R; Pansuriya, BR; Parmar, NJ | 1 |
| Ganesh Kumar, C; Poornima, M; Prabhavathi Devi, BL; Prasad, RB; Reddy, TV | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Wang, SQ; Wang, YF; Xu, Z | 1 |
| Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
| Osborne, PJ; Quirk, PC; Walsh, LJ | 1 |
| Castagnaro, L; Cunningham, CK; Flynn, PM; Gilbert, G; Harris, J; Kerkering, T; Peters, VB; Pitel, PA; Robinson, P; San Jorge, AR | 1 |
| Buser, U; Egger, T; Gratwohl, A; Passweg, J; Pless, M; Stebler Gysi, C; Tichelli, A; Uhr, M; Wernli, M; Wuhrmann, J | 1 |
| Boillot, F; Fournier, C; Gaspar, A; Villard, J | 1 |
| Ninane, J | 1 |
| Greenspan, D | 1 |
| Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B | 1 |
| Brammer, KW; Ehninger, G; Mufti, GJ; Philpott-Howard, JN; Wade, JJ | 1 |
| Johnson, EM; Warnock, DW; White, DJ | 1 |
| Czaika, V; Hopp, M; Kunzelmann, V; Rossner, D; Schmalreck, A; Sterry, W; Tietz, HJ | 1 |
| Barrios, C; Cuervas-Mons, V; del Palacio, A; Jara, P; Lumbreras, C; Moreno, E; Noriega, AR; Paya, CV; Turrión, VS | 1 |
| Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Smith, JG | 1 |
| Barranco, A; Gallant, JE; Green, S; Greenspan, D; Johnson, CC; Levenstein, M; Lozada-Nur, F; McCarty, J; McPhail, L; Panzer, H; Pons, V; Tunkel, A | 1 |
| Evans, S; Leake, H; Ustianowski, AP | 1 |
| Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U | 1 |
| Huang, SS; Huang, TZ; Liu, CC; Wang, JN; Wu, JM | 1 |
| Burgaleta, C | 1 |
| Groll, AH; Just-Nuebling, G; Kornhuber, B; Kurz, M; Mueller, C; Nowak-Goettl, U; Schwabe, D; Shah, PM | 1 |
| Aguado, JM; Colina, F; del Palacio, A; Gómez, R; Herrero, JA; Lizasoain, M; Lumbreras, C; Miguélez, M; Moreno, E; Rodríguez-Noriega, A | 1 |
| Ellepola, AN; Samaranayake, LP | 6 |
| Berggren, U; Blomgren, J; Jontell, M | 1 |
| Adachi, A; Horikawa, T; Ichihashi, M; Komura, A; Takashima, T | 1 |
| Bacher, J; Calendario, M; Field-Ridley, A; Groll, AH; Petraitiene, R; Petraitis, V; Piscitelli, SC; Walsh, TJ | 1 |
| Carrillo-Muñoz, AJ; Cossum, PA; del Valle, O; Miranda, Y; Quindós, G; Ruesga, MT; Tur, C; Wallace, TL | 1 |
| Bujdáková, H; Dierich, MP; Gruber, A; Klobusický, M; Kurisková, S; Langgartner, M; Lell, CP; Spötl, L; Würzner, R | 1 |
| Gotzsche, PC; Johansen, HK | 1 |
| Bosly, A; Durrant, S; Gibbs, DL; Young, GA | 1 |
| Drew, SV; Low, L; Matthews, P | 1 |
| Chow, CK; Lawrence, HP; Matear, DW | 1 |
| Niki, Y | 1 |
| Olarinde, O; Watson, MG | 1 |
| Buslaeva, GN | 1 |
| Bell, PM; Coulter, WA; Fulton, CR; Hayes, JR; Lamey, PJ; Willis, AM | 1 |
| Chandra, J; Douglas, LJ; Faddoul, FF; Ghannoum, MA; Hoyer, LL; Leidich, SD; Mukherjee, PK | 1 |
| Bojtarova, E; Ilavska, I; Krcmery, V; Krupova, Y; Mistrik, M; Sejnova, D | 1 |
| Bonito, AJ; Patton, LL; Shugars, DA | 1 |
| Anil, S; Ellepola, AN; Samaranayake, LP | 1 |
| Brent, NB | 1 |
| Arikan, S; Gordon, D; Lozano-Chiu, M; Ostrosky-Zeichner, L; Paetznick, V; Rex, JH; Wallace, T | 1 |
| Lima, SM; Martins, RS; Mesquita, RA; Péreira, ES; Santos, VR; Senna, MI | 1 |
| Casalaz, D | 1 |
| Gøtzsche, PC; Johansen, HK | 4 |
| Bauters, TG; Moerman, M; Nelis, HJ; Vermeersch, H | 1 |
| Anil, S; Samaranayake, LP | 1 |
| Arnold, J; Ascher, D; Goins, RA; Moorefield, E; Waecker, N | 1 |
| Shepherd, J | 1 |
| Pérez Prim, FJ; Vila, I | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
| Austin, NC; Darlow, B | 1 |
| Chen, A; Epstein, JB; Epstein, JD; Fritsche, TR; Hanson-Huggins, K; Mancl, LA; Petersdorf, SH; Press, OW; Truelove, EL | 1 |
| Dhaliwal, HS; Oliver, RJ; Pemberton, MN; Theaker, ED | 1 |
| Marrazzo, J | 1 |
| Spence, D | 3 |
| Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
| Blignaut, E; Botes, ME; Nieman, HL | 1 |
| Chen, FC; Lin, M | 1 |
| Hua, H; Liu, X | 1 |
| Dempsey, EM; O'Grady, MJ | 1 |
| Isaacs, D | 1 |
| Gaskie, S; Jamieson, B; Su, CW; Triezenberg, D | 1 |
| Kaufman, DA | 2 |
| da Silva, WJ; Del bel Cury, AA; Rached, RN; Rosalen, PL | 1 |
| Bateman, D; Carbone, T; Doraiswamy, B; LaCorte, M; Olawepo, O; Violaris, K | 1 |
| Chandran, SK; Divi, V; Geyer, M; Lyons, KM; Sataloff, RT | 1 |
| Austin, N; Darlow, BA; McGuire, W | 2 |
| Fan, SR; Liu, XP | 1 |
| Akar, M; Aydemir, C; Dilmen, U; Dizdar, EA; Erdeve, O; Oguz, SS; Sarikabadayi, YU; Saygan, S | 1 |
| Billings, SD; Hoschar, AP; McDonnell, JK; Rushing, EC | 1 |
| Eller, AW; Mayercik, VA; Pihlblad, MS | 1 |
| Consolaro, ME; da Silva, MC; Martins, HP; Paiva, LC; Svidzinski, TI | 1 |
| Leibovitz, E | 1 |
| Al-Dwairi, ZN; Al-Omari, OY; Al-Quran, FA | 1 |
| Barzi, F; Blyth, CC; Hale, K; Isaacs, D | 1 |
| de Souza Bonfim-Mendonça, P; Fiorini, A; Godoy, JS; Nakamura, SS; Pieralisi, N; Shinobu-Mesquita, C; Svidzinski, TI; Yamada, SS | 1 |
| Chauhan, NM; Karuppayil, SM; Raut, JS; Shinde, RB | 1 |
| Casal, M; Castón, JJ; Linares, MJ; Rivero, A; Torre-Cisneros, J | 1 |
| Apratim, A; Chopde, N; Khade, MN; Khadtare, YR; Pharande, A; Shah, SS | 1 |
| Boano, E; Castagnola, E; De Luca, D; Farina, D; Jacqz-Aigrain, E; Luparia, M; Manzoni, P; Mostert, M; Ruffinazzi, G; Stronati, M; Tavella, E | 1 |
| da Silva, WJ; Del Bel Cury, AA; Gonçalves, LM; Parahitiyawa, N; Samaranayake, LP; Seneviratne, J | 1 |
| Ban, X; Chen, Y; Ma, B; Tian, J; Wang, Y; Zeng, H | 1 |
| Kunicka-Styczyńska, A; Maroszyńska, I; Maroszyńska, M; Rajkowska, K | 1 |
| Bradshaw, WT; Lollis, TR | 1 |
| Alviano, DS; Barreto, AL; Curvelo, JA; Holandino, C; Portela, MB; Soares, RM; Souto-Padrón, T | 1 |
| Anil, S; Bandara, HM; Hashem, M; Patil, S; Samaranayake, LP; Vellappally, S | 1 |
| Fan, S; Li, J; Liu, X; Shan, Y; Zhu, Y | 1 |
| Bandara, HM; Ellepola, AN; Joseph, BK; Khan, ZU; Samaranayake, LP | 1 |
| Fan, S; Li, J; Liu, X; Wu, C; Xu, L | 1 |
| Lewis, M | 1 |
| Ellepola, AN; Jayathilake, JA; Khan, ZU; Sharma, PN | 1 |
| Abu-Hammad, OA; Al-Omiri, MK; Al-Shayyab, MH; Dar-Odeh, NS | 1 |
| Aydin, A; Kantarcioglu, AS; Kiraz, N | 1 |
| Austin, N; Cleminson, J; Darlow, BA; McGuire, W | 1 |
| Araya, I; Camponovo, R; Carrillo-Muñoz, AJ; Cerda, A; Diaz, MC; Santander, MP | 1 |
| Freires, IA; Fusco-Almeida, AM; Gullo, FP; Mendes-Giannini, MJ; Pitangui, NS; Regasini, LO; Rosalen, PL; Sardi, JC; Segalla, MP | 1 |
| Anwar, A; Khan, NA; Rajendran, K; Siddiqui, R | 1 |
| Ahmed, D; Anwar, A; Hussain, MA; Khan, NA; Shah, MR; Siddiqui, R | 1 |
| de Abajo, FJ; Gaist, D; Martín-Pérez, M; Rodríguez, LAG | 1 |
| Dawgul, MA; Grzywacz, D; Kamysz, W; Liberek, B; Myszka, H | 1 |
| Abutalebian, S; Bahardoost, M; Daie Ghazvini, R; Elahi, M; Gerami Shoar, M; Hashemi, SJ; Kamali Sarwestani, Z; Mahmoudi, S; Rezaie, S; Tajdini, A | 1 |
| Beysenbekova, Z; Tayzhanova, D; Toleuova, A; Toyynbekova, R | 1 |
| Aitken-Saavedra, J; Fernandez-Ramires, R; González, J; Huenchunao, R; Lund, RG; Martos, J; Maturana-Ramírez, A; Molina-Berríos, A; Morales-Bozo, I; Perez-Vallespir, I; Tarquinio, SC; Urzúa, B | 1 |
| Ahmed Khan, N; Anwar, A; Raza Shah, M; Siddiqui, R | 1 |
| Kader, NA; Patil, S; Raj, AT; Seetharam, C; Sujatha, G | 1 |
| El-Houssaini, HH; Elkhatib, WF; Elnabawy, OM; Nasser, HA | 1 |
| Ahmed, D; Ahmed, S; Anis, I; Anwar, A; Hussain, MA; Khan, NA; Perveen, S; Shah, MR | 1 |
| Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E | 1 |
| Hay, RJ; Jemec, GBE; Saunte, DML; Taudorf, EH | 1 |
| Alves, MM; Barbosa, DB; Delbem, ACB; Figueiral, MH; Lopes, MM; Mira, NP; Pinto, E; Souza, JAS | 1 |
| Marsogi, M; Oeswadi, CA; Purnamasari, A; Rundjan, L; Wahyuningsih, R | 1 |
| Bassi, RC; Boriollo, MFG | 1 |
| Carmello, JC; Dias, LM; Jordão, CC; Klein, MI; Pavarina, AC | 1 |
| Asch, WS; Casal, GH; Cohen, EA; Johnston, JP; Reardon, DP | 1 |
| Blyth, CC; Cooper, C; James, R; Jones, CA; Konecny, P; McMullan, BJ; Spotswood, N; Thursky, KA | 1 |
| Budini, M; Cid-Chevecich, C; Criollo, A; Díaz-Dosque, M; Escobar, A; Jara, JA; López-Muñoz, R; Molina-Berríos, A; Müller-Sepúlveda, A; Quijada, R; Santander, R | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Aggrey, MO; Amengor, CD; Fleischer, TC; Harley, BK; Jato, J; Mireku-Gyimah, NA; Neglo, D; Orman, E; Quagraine, AM; Saaka, Y | 1 |
| Abdel-Aziz, HMM; El-Zayat, MM; Hasaneen, MNA; Helal, SH | 1 |
| Hu, Q; Li, T; Liu, N; Liu, Q; Peng, Y; Yang, J | 1 |
33 review(s) available for fluconazole and nystatin a1
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Oral; CD4-Positive T-Lymphocytes; Clotrimazole; Fluconazole; HIV Infections; Humans; Ketoconazole; Leukocyte Count; Nystatin; Risk Factors | 1994 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mucormycosis; Mycoses; Neutropenia; Nystatin; Primary Prevention; Recurrence; Retrospective Studies | 1995 |
Recurrent vaginal thrush and soreness.
Topics: Adult; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Diagnosis, Differential; Family Practice; Female; Fluconazole; Humans; Nystatin; Recurrence; Sexual Partners | 1999 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence | 2000 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Mycoses; Nystatin; Opportunistic Infections | 2002 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Mycoses; Nystatin; Opportunistic Infections; Randomized Controlled Trials as Topic | 2002 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
Prophylactic oral antifungal agents to prevent systemic candida infection in preterm infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Nystatin; Randomized Controlled Trials as Topic | 2004 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Sexual Partners | 2003 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Nystatin; Secondary Prevention; Sexual Partners | 2003 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Nystatin; Secondary Prevention | 2004 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Nystatin; Secondary Prevention | 2005 |
Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
Topics: Administration, Oral; Antifungal Agents; Cross Infection; Fluconazole; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Mycoses; Nystatin; Risk Factors | 2008 |
Clinical inquiries. What is the best treatment for oral thrush in healthy infants?
Topics: Administration, Oral; Anti-Infective Agents, Local; Antifungal Agents; Candidiasis, Oral; Evidence-Based Medicine; Family Practice; Fluconazole; Gentian Violet; Humans; Infant; Infant Care; Infant, Newborn; Nystatin; Practice Guidelines as Topic | 2008 |
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Nystatin; Randomized Controlled Trials as Topic | 2009 |
Strategies for the prevention of neonatal candidiasis.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Nystatin | 2012 |
"Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.
Topics: Antifungal Agents; Candidiasis, Invasive; Fluconazole; Humans; Infant, Newborn; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Intensive Care Units, Neonatal; Nystatin; Premature Birth | 2012 |
Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin.
Topics: Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Mycoses; Nystatin; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
Prevention of nosocomial infections in neonatal intensive care units.
Topics: Anti-Infective Agents; Central Venous Catheters; Contraindications; Cross Infection; Fluconazole; Histamine H2 Antagonists; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Lactoferrin; Milk, Human; Nystatin; Pneumonia, Ventilator-Associated; Probiotics; Sepsis | 2013 |
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Mycoses; Nystatin; Randomized Controlled Trials as Topic | 2013 |
Fungal prophylaxis in neonates: a review article.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; Candidemia; Fluconazole; Fungemia; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Malassezia; Nystatin; Zygomycosis | 2014 |
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Confidence Intervals; Fluconazole; Humans; Injections, Intravenous; Mycoses; Neoplasms; Neutropenia; Nystatin; Odds Ratio; Randomized Controlled Trials as Topic | 2014 |
Nystatin prophylaxis and treatment in severely immunodepressed patients.
Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Liposomes; Mycoses; Nystatin; Opportunistic Infections; Randomized Controlled Trials as Topic | 2014 |
Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Miconazole; Mycoses; Nystatin; Randomized Controlled Trials as Topic | 2015 |
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles | 2019 |
Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Cutaneous; Clotrimazole; Drug Therapy, Combination; Evidence-Based Medicine; Fluconazole; Humans; Ketoconazole; Miconazole; Nystatin | 2019 |
Efficacy of photodynamic therapy in the treatment of oral candidiasis: a systematic review and meta-analysis.
Topics: Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Miconazole; Nystatin; Photochemotherapy | 2023 |
19 trial(s) available for fluconazole and nystatin a1
| Article | Year |
|---|---|
Australian Dental Research Fund Trebitsch Scholarship. Efficacy of antifungal prophylaxis in bone marrow transplantation.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Bone Marrow Transplantation; Candidiasis, Oral; Child; Drug Combinations; Fellowships and Scholarships; Female; Fluconazole; Humans; Male; Middle Aged; Mouthwashes; Nystatin; Prospective Studies; Retrospective Studies | 1995 |
Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group.
Topics: Administration, Oral; Adolescent; Candidiasis, Oral; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Fluconazole; HIV Infections; Humans; Immunocompromised Host; Immunosuppression Therapy; Infant; Neoplasms; Nystatin; Recurrence | 1995 |
Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients. A prospective, randomized, single-center study.
Topics: Adolescent; Adult; Aged; Female; Fluconazole; Humans; Immunocompromised Host; Male; Miconazole; Middle Aged; Mycoses; Neutropenia; Nystatin; Prospective Studies | 1995 |
A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group.
Topics: Administration, Oral; Adolescent; Amphotericin B; Candida; Child; Child, Preschool; Female; Fluconazole; Hematologic Diseases; Humans; Immunocompromised Host; Infant; Infant, Newborn; Male; Mycoses; Neoplasms; Nystatin | 1994 |
Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Child; Female; Fluconazole; Humans; Male; Middle Aged; Mycoses; Neutropenia; Nystatin | 1993 |
[Prerequisites for effective therapy of chronic recurrent vaginal candidiasis].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Child; Child, Preschool; Chronic Disease; Female; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Recurrence | 1996 |
Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.
Topics: Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Humans; Liver Transplantation; Male; Middle Aged; Nystatin | 1996 |
Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Nystatin; Pharyngeal Diseases; Suspensions | 1997 |
Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents; Candida albicans; Candidiasis; Child; Child, Preschool; Feces; Female; Fluconazole; Humans; Infant; Male; Neoplasms; Nystatin; Oropharynx; Prospective Studies; Pruritus | 1997 |
Fluconazole versus nystatin in the treatment of oral candidosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Capsules; Dentures; Erythema; Female; Fluconazole; Follow-Up Studies; HIV Infections; Humans; Immunosuppression Therapy; Male; Middle Aged; Mouth Mucosa; Mouthwashes; Nystatin; Organ Transplantation; Patient Compliance; Patient Satisfaction; Recurrence; Risk Factors; Xerostomia | 1998 |
A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Double-Blind Method; Female; Fluconazole; Humans; Leukemia; Male; Middle Aged; Neutropenia; Nystatin; Opportunistic Infections; Treatment Outcome | 1999 |
The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
Topics: Analysis of Variance; Antifungal Agents; Bacterial Adhesion; Candida albicans; Candidiasis, Oral; Chi-Square Distribution; Diabetes Mellitus, Type 1; Epithelial Cells; Female; Fluconazole; Humans; Male; Middle Aged; Nystatin; Phospholipases; Prospective Studies; Virulence | 2001 |
Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants.
Topics: Administration, Oral; Analysis of Variance; Antifungal Agents; Candidiasis, Oral; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Nystatin; Probability; Prospective Studies; Treatment Outcome | 2002 |
Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis, Oral; Female; Fluconazole; Gingivitis, Necrotizing Ulcerative; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mouth; Mouthwashes; Nystatin; Polyenes; Severity of Illness Index; Time Factors; Treatment Outcome | 2004 |
Effects of nystatin, fluconazole and propolis on poly(methyl methacrylate) resin surface.
Topics: Acrylic Resins; Anti-Infective Agents; Antifungal Agents; Dental Materials; Dental Polishing; Fluconazole; Hardness; Hot Temperature; Humans; Materials Testing; Microwaves; Nystatin; Pharmaceutical Vehicles; Polymethyl Methacrylate; Propolis; Surface Properties; Surface Tension; Time Factors; Toothbrushing; Toothpastes; Water; Wettability | 2008 |
Comparison of fluconazole and nystatin oral suspensions for prophylaxis of systemic fungal infection in very low birthweight infants.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Mycoses; Nystatin; Treatment Outcome | 2010 |
Randomised controlled trial of prophylactic fluconazole versus nystatin for the prevention of fungal colonisation and invasive fungal infection in very low birth weight infants.
Topics: Antifungal Agents; Birth Weight; Disease Progression; Drug Resistance, Fungal; Epidemiologic Methods; Female; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Male; Microbial Sensitivity Tests; Mycoses; Nystatin; Treatment Outcome | 2011 |
Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
Topics: Antifungal Agents; Biofilms; Candida albicans; Colorimetry; Culture Media; Fluconazole; Fungal Polysaccharides; Humans; Hyphae; Indicators and Reagents; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Confocal; Nystatin; Polymethyl Methacrylate; Solubility; Surface Properties; Tetrazolium Salts; Time Factors | 2012 |
Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: a randomized controlled trial.
Topics: Antifungal Agents; Fluconazole; Humans; Indonesia; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Infant, Very Low Birth Weight; Mycoses; Nystatin; Prospective Studies | 2020 |
103 other study(ies) available for fluconazole and nystatin a1
| Article | Year |
|---|---|
Synthesis of (1,4)-naphthoquinono-[3,2-c]-1H-pyrazoles and their (1,4)-naphthohydroquinone derivatives as antifungal, antibacterial, and anticancer agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Candida albicans; Carcinoma 256, Walker; Cryptococcus neoformans; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Naphthoquinones; Pyrazoles; Rats; Structure-Activity Relationship | 2005 |
Synthesis and biological evaluation of novel (L)-alpha-amino acid methyl ester, heteroalkyl, and aryl substituted 1,4-naphthoquinone derivatives as antifungal and antibacterial agents.
Topics: Amino Acids; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Methyl Ethers; Molecular Structure; Naphthoquinones | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis; Catheterization, Central Venous; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fungemia; Fungi; Humans; Microbial Sensitivity Tests | 2008 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Fungal; Drug Resistance, Fungal; Ergosterol; Genes, Fungal; Guanine; Humans; Molecular Sequence Data; Polyenes | 2008 |
2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6,11-diones and related compounds: synthesis and biological evaluation as potential antiproliferative and antifungal agents.
Topics: Antifungal Agents; Antineoplastic Agents; Cell Proliferation; HeLa Cells; Humans; Hydroquinones; Phenothiazines; Sporothrix; Structure-Activity Relationship | 2009 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Design, synthesis and biological evaluation of novel nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Drug Design; Fungi; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur | 2009 |
'On water' assisted synthesis and biological evaluation of nitrogen and sulfur containing hetero-1,4-naphthoquinones as potent antifungal and antibacterial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Fungi; Green Chemistry Technology; Microbial Sensitivity Tests; Naphthoquinones; Nitrogen; Sulfur; Water | 2010 |
Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives as antibacterial and antifungal agents.
Topics: Anti-Infective Agents; Candida albicans; Escherichia coli; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Pyridines; Pyrroles; Spectrophotometry, Infrared; Staphylococcus aureus | 2010 |
Synthesis and antimycobacterial properties of N-substituted 6-amino-5-cyanopyrazine-2-carboxamides.
Topics: Amides; Amines; Anti-Bacterial Agents; Microbial Viability; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Pyrazines; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Micelles catalyzed chemoselective synthesis 'in water' and biological evaluation of oxygen containing hetero-1,4-naphthoquinones as potential antifungal agents.
Topics: Antifungal Agents; Candida; Catalysis; Drug Evaluation, Preclinical; Micelles; Microbial Sensitivity Tests; Naphthoquinones; Oxygen; Sporothrix; Trichophyton; Water | 2011 |
Novel dendrimeric lipopeptides with antifungal activity.
Topics: Antifungal Agents; Bacteria; Candida; Cations; Dendrimers; Drug Design; Erythrocytes; Glucosyltransferases; Humans; Lipopeptides; Microbial Sensitivity Tests; Molecular Structure | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
An efficient one-pot synthesis, structure, antimicrobial and antioxidant investigations of some novel quinolyldibenzo[b,e][1,4]diazepinones.
Topics: Anti-Infective Agents; Antioxidants; Azepines; Crystallography, X-Ray; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Conformation; Quinolines | 2012 |
An improved microwave assisted one-pot synthesis, and biological investigations of some novel aryldiazenyl chromeno fused pyrrolidines.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Azo Compounds; Benzopyrans; Candida albicans; Crystallography, X-Ray; Gram-Negative Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Stereoisomerism; Thiosemicarbazones | 2012 |
Total synthesis and antifungal activity of (2S,3R)-2-aminododecan-3-ol.
Topics: Antifungal Agents; Candida; Dodecanol; Molecular Structure | 2012 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Evaluation of a broth microdilution antifungal susceptibility test with a pH indicator: comparison with the broth macrodilution procedures.
Topics: Amphotericin B; Antifungal Agents; Bromcresol Purple; Candida; Culture Media; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Fluconazole; Fungi; Hydrogen-Ion Concentration; Indicators and Reagents; Microbial Sensitivity Tests; Nystatin; Saccharomyces cerevisiae | 1995 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies | 1994 |
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Econazole; Female; Fluconazole; Gentian Violet; Humans; Itraconazole; Ketoconazole; Medroxyprogesterone Acetate; Microbial Sensitivity Tests; Nystatin | 1993 |
New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antifungal Agents; Candida albicans; CD4-Positive T-Lymphocytes; Digestive System; Disease Models, Animal; Female; Fluconazole; Ketoconazole; Mice; Mice, Inbred DBA; Microbial Sensitivity Tests; Nystatin; Oropharynx; Peptides; Peptides, Cyclic | 1996 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum | 1997 |
Laryngeal candidiasis in children.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Humans; Infant; Laryngeal Diseases; Laryngoscopy; Larynx; Male; Nystatin | 1997 |
[Invasive fungal infections in liver transplant recipients: analysis of 21 cases].
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Fluconazole; Humans; Liver Transplantation; Male; Middle Aged; Mycoses; Nystatin; Retrospective Studies; Severity of Illness Index | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin | 1998 |
Adhesion of oral C. albicans to human buccal epithelial cells following limited exposure to antifungal agents.
Topics: Antifungal Agents; Candida albicans; Cell Adhesion; Cheek; Epithelial Cells; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Male; Microscopy, Electron, Scanning; Mouth Mucosa; Nystatin | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors | 1998 |
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin | 1998 |
[Role of Candida allergen in atopic dermatitis and efficacy of oral therapy with various antifungal agents].
Topics: Administration, Oral; Adult; Allergens; Amphotericin B; Antifungal Agents; Antigens, Fungal; Candida albicans; Dermatitis, Atopic; Female; Fluconazole; Humans; Itraconazole; Male; Nystatin | 1999 |
Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Drug Carriers; Fluconazole; Liposomes; Nystatin; Rabbits; Treatment Outcome | 1999 |
In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Deoxycholic Acid; Drug Carriers; Drug Combinations; Fluconazole; Humans; Itraconazole; Liposomes; Microbial Sensitivity Tests; Nystatin; Phosphatidylcholines; Phosphatidylglycerols | 1999 |
The influence of subinhibitory concentrations of conventional and experimental antifungal drugs on the expression of the iC3b binding protein in Candida albicans strains during filamentation.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Clotrimazole; Complement C3b; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Fluconazole; Humans; Immunoblotting; Microbial Sensitivity Tests; Nystatin; Receptors, Complement 3b; Rosette Formation; Sheep; Species Specificity; Thiazoles; Tunicamycin | 1999 |
Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Meta-Analysis as Topic; Mycoses; Neoplasms; Neutropenia; Nystatin; Opportunistic Infections; Publication Bias; Randomized Controlled Trials as Topic; Research Design | 1999 |
Efficacy of antifungal agents in tissue conditioners in treating candidiasis.
Topics: Acrylic Resins; Aged; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Dental Care for Aged; Denture Liners; Drug Combinations; Drug Delivery Systems; Fluconazole; Humans; Itraconazole; Methylmethacrylates; Microbial Sensitivity Tests; Nystatin; Phthalic Acids; Statistics, Nonparametric; Stomatitis, Denture; Tissue Conditioning, Dental | 1999 |
[Therapy of deep seated mycoses--Timing of administration and selection of antifungal agents].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2000 |
Candidal abscess in a second primary neoplasm of the neopharynx.
Topics: Antifungal Agents; Candidiasis; Carcinoma, Squamous Cell; Fluconazole; Humans; Male; Middle Aged; Neoplasms, Second Primary; Nystatin; Pharyngeal Neoplasms; Retropharyngeal Abscess; Treatment Outcome | 2000 |
[Current problems in etiotropic therapy of mycoses].
Topics: Amphotericin B; Antifungal Agents; Candicidin; Candida; Fluconazole; Humans; Itraconazole; Miconazole; Mycoses; Nystatin | 2001 |
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.
Topics: Acrylic Resins; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Chlorhexidine; Colony Count, Microbial; Denture Bases; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluconazole; Galactose; Glucose; Humans; Indicators and Reagents; Nystatin; Polymethyl Methacrylate; Saliva; Statistics as Topic; Stomatitis, Denture; Sucrose; Tetrazolium Salts; Time Factors | 2001 |
Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Female; Fluconazole; Humans; Liposomes; Lung Diseases, Fungal; Male; Middle Aged; Neoplasms; Nystatin; Treatment Failure; Treatment Outcome | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence | 2001 |
Thrush in the breastfeeding dyad: results of a survey on diagnosis and treatment.
Topics: Adult; Antifungal Agents; Breast Diseases; Breast Feeding; Candidiasis; Candidiasis, Oral; Female; Fluconazole; Humans; Infant; Infant, Newborn; Mouth Diseases; Nipples; Nystatin; Recurrence; Weaning | 2001 |
In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Drug Resistance, Fungal; Fluconazole; Humans; Liposomes; Microbial Sensitivity Tests; Nystatin | 2002 |
Effect of commercial ethanol propolis extract on the in vitro growth of Candida albicans collected from HIV-seropositive and HIV-seronegative Brazilian patients with oral candidiasis.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Brazil; Candida albicans; Candidiasis, Oral; Clotrimazole; Complementary Therapies; Drug Resistance, Fungal; Econazole; Ethanol; Fluconazole; HIV Seronegativity; HIV Seropositivity; Humans; Nystatin; Propolis; Solvents; Statistics, Nonparametric | 2002 |
Fluconazole prophylaxis against fungal infection in preterm infants.
Topics: Administration, Oral; Antifungal Agents; Candida; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Mycoses; Nystatin | 2002 |
Colonization of voice prostheses by albicans and non-albicans Candida species.
Topics: Aged; Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Humans; Larynx, Artificial; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Prevalence; Prosthesis-Related Infections | 2002 |
Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole.
Topics: Amphotericin B; Analysis of Variance; Anti-Infective Agents; Antifungal Agents; Candida albicans; Candida tropicalis; Colony Count, Microbial; Fluconazole; Humans; Lactoferrin; Microbial Sensitivity Tests; Mouth; Muramidase; Nystatin; Species Specificity; Statistics as Topic | 2002 |
Thrush and breastfeeding.
Topics: Antifungal Agents; Breast Diseases; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Fluconazole; Humans; Infant; Infant, Newborn; Lactation; Male; Nipples; Nystatin; Pain; Weaning | 2002 |
[Ongoing treatment with omeprazole and appearance of oropharyngeal candidiasis].
Topics: Aged; Anti-Ulcer Agents; Antifungal Agents; Candida albicans; Candidiasis, Oral; Female; Fluconazole; Gastroesophageal Reflux; Humans; Nystatin; Omeprazole; Treatment Failure | 2002 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
Patterns of antifungal prescribing in general dental practice.
Topics: Age Factors; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Prescriptions; Fluconazole; General Practice, Dental; Humans; Miconazole; Nystatin; Practice Patterns, Dentists'; Surveys and Questionnaires; United Kingdom | 2004 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
The treatment of oral candidiasis in a cohort of South African HIV/AIDS patients.
Topics: Adolescent; Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Chemoprevention; Chronic Disease; Cohort Studies; Comprehensive Health Care; Female; Fluconazole; Follow-Up Studies; Heterosexuality; Humans; Itraconazole; Male; Miconazole; Middle Aged; Nystatin; Population Surveillance; Retrospective Studies; South Africa; Treatment Outcome | 1999 |
[Oral isolates of Saccharomyces in patients with oral fungal infection and their susceptibility to antifungal drugs].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Fluconazole; Humans; Ketoconazole; Nystatin; Saccharomyces | 2007 |
Oral manifestation of chronic mucocutaneous candidiasis: seven case reports.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Candidiasis, Oral; Child; Female; Fluconazole; Humans; Male; Middle Aged; Mouth Mucosa; Nystatin | 2007 |
Antifungal prophylaxis for the prevention of neonatal candidiasis?
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Fluconazole; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Very Low Birth Weight; Nystatin; Practice Patterns, Physicians' | 2008 |
Prevention of invasive Candida infections in preterm infants: the time is now.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Meningitis, Fungal; Nystatin; Premature Birth; Prevalence; United States | 2008 |
Fungal laryngitis.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Antifungal Agents; Candidiasis; Disease Susceptibility; Female; Fluconazole; Follow-Up Studies; Humans; Laryngitis; Nystatin; Pulmonary Disease, Chronic Obstructive; Recurrence; Retreatment | 2009 |
In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Nystatin; Treatment Outcome | 2011 |
Iatrogenic oral hairy leukoplakia: report of two cases.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clobetasol; Dapsone; Dermatologic Agents; Dexamethasone; Diabetes Mellitus, Type 2; Epstein-Barr Virus Infections; Female; Fluconazole; Humans; Immunocompromised Host; Leukoplakia, Hairy; Lichen Planus; Methotrexate; Nystatin; Prednisone; Zinc Oxide | 2011 |
Fungal endophthalmitis developing in asthmatic individuals treated with inhaled corticosteroids.
Topics: Administration, Inhalation; Aged; Amphotericin B; Anti-Asthmatic Agents; Asthma; Candidemia; Candidiasis, Oral; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Glucocorticoids; Humans; Nystatin; Risk Factors | 2011 |
Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Brazil; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Middle Aged; Nystatin; Treatment Outcome; Young Adult | 2012 |
The effect of antifungal agents on surface properties of poly(methyl methacrylate) and its relation to adherence of Candida albicans.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Nystatin; Polymethyl Methacrylate; Surface Properties | 2012 |
Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colony Count, Microbial; Dentures; Diabetes Complications; Echinocandins; Female; Fluconazole; Humans; Hypertension; Kidney Failure, Chronic; Lipopeptides; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Mycology; Nystatin; Phenotype; Pyrimidines; Renal Dialysis; Time Factors; Triazoles; Voriconazole | 2013 |
Sensitization of Candida albicans biofilms to various antifungal drugs by cyclosporine A.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Cyclosporine; Drug Resistance, Multiple, Fungal; Drug Synergism; Echinocandins; Fluconazole; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Asthma; Bacterial Infections; Carrier State; Chronic Disease; Comorbidity; Cross Infection; Diagnosis, Differential; Disease Susceptibility; Female; Fluconazole; Hospitals, University; Humans; Incidence; Invasive Pulmonary Aspergillosis; Length of Stay; Lung; Lung Diseases; Male; Middle Aged; Nystatin; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Respiratory Insufficiency; Retrospective Studies; Risk Factors; Spain | 2012 |
In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
Topics: Antifungal Agents; Candida albicans; Colony Count, Microbial; Denture Bases; Denture Liners; Fluconazole; Humans; Materials Testing; Methacrylates; Methylmethacrylates; Miconazole; Microbial Sensitivity Tests; Microbial Viability; Nystatin; Phthalic Acids; Tissue Conditioning, Dental | 2012 |
Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans.
Topics: Anethum graveolens; Antifungal Agents; Candida albicans; Cell Membrane; Cysteine; Ergosterol; Flow Cytometry; Fluconazole; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Mitochondria; Nystatin; Oils, Volatile; Oxidoreductases; Plant Oils; Reactive Oxygen Species; Seeds | 2013 |
Antibiotics sensitivity of Candida clinical and food-borne isolates.
Topics: Candida; Caspofungin; Drug Resistance, Bacterial; Echinocandins; Fluconazole; Food Microbiology; Foodborne Diseases; Humans; Lipopeptides; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2013 |
Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative?
Topics: Antifungal Agents; Biological Phenomena; Candida albicans; Cell Adhesion; Drug Resistance, Fungal; Flow Cytometry; Fluconazole; Humans; In Vitro Techniques; Membrane Glycoproteins; Microbial Sensitivity Tests; Microscopy, Electron; Nystatin; Secretory Leukocyte Peptidase Inhibitor | 2014 |
Sub-inhibitory concentrations of antifungals suppress hemolysin activity of oral Candida albicans and Candida tropicalis isolates from HIV-infected individuals.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis, Oral; Fluconazole; Hemolysin Proteins; HIV Infections; Humans; Microbiological Techniques; Nystatin; Virulence Factors | 2014 |
Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Miconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Nystatin; Retrospective Studies | 2015 |
Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Nystatin | 2016 |
Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Nystatin; Recurrence; Treatment Outcome; Vagina; Vulva; Young Adult | 2015 |
The role of antifungal and antiviral agents in primary dental care.
Topics: Acyclovir; Amphotericin B; Antifungal Agents; Antiviral Agents; Candidiasis, Oral; Cheilitis; Dental Care; Fluconazole; Glossitis; Guanine; Herpes Zoster; Humans; Miconazole; Mouth Diseases; Nystatin; Primary Health Care; Stomatitis, Herpetic | 2014 |
Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Chlorhexidine; Echinocandins; Fluconazole; Hemolysin Proteins; Humans; Ketoconazole; Kuwait; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Sri Lanka; Time Factors | 2016 |
Antifungal prescribing pattern and attitude towards the treatment of oral candidiasis among dentists in Jordan.
Topics: Administration, Topical; Adult; Aged; Amphotericin B; Antifungal Agents; Attitude of Health Personnel; Candidiasis, Oral; Cross-Sectional Studies; Drug Prescriptions; Female; Fluconazole; Humans; Jordan; Male; Miconazole; Middle Aged; Nystatin; Practice Patterns, Dentists'; Private Practice; Professional Practice; Public Health Dentistry; Referral and Consultation; Sex Factors; Workplace | 2015 |
Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole.
Topics: Adolescent; Antifungal Agents; Autism Spectrum Disorder; Child; Child, Preschool; Female; Fluconazole; Gastrointestinal Tract; Humans; Male; Microbial Sensitivity Tests; Nystatin; Retrospective Studies; Yeasts | 2016 |
[Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Nystatin | 2016 |
Synthesis, antifungal activity of caffeic acid derivative esters, and their synergism with fluconazole and nystatin against Candida spp.
Topics: Antifungal Agents; Caffeic Acids; Candida albicans; Candidiasis; Cells, Cultured; Drug Synergism; Esters; Fluconazole; Humans; Inhibitory Concentration 50; Keratinocytes; Microbial Sensitivity Tests; Molecular Structure; Nystatin | 2016 |
Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri.
Topics: Amebicides; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Fluconazole; Metal Nanoparticles; Naegleria fowleri; Nanocapsules; Nanoconjugates; Nystatin; Particle Size; Silver; Survival Rate; Treatment Outcome | 2017 |
Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole.
Topics: Acanthamoeba castellanii; Amebiasis; Amebicides; Amphotericin B; Fluconazole; Humans; Metal Nanoparticles; Microscopy, Atomic Force; Nystatin; Silver; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared | 2018 |
Population Impact of Drug Interactions with Warfarin: A Real-World Data Approach.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anticoagulants; Carbamazepine; Databases, Factual; Drug Interactions; Female; Fluconazole; Follow-Up Studies; Humans; International Normalized Ratio; Male; Miconazole; Middle Aged; Nystatin; Primary Health Care; Retrospective Studies; United Kingdom; Warfarin; Young Adult | 2018 |
Activity of Diosgenyl 2-amino-2-deoxy-β-D-glucopyranoside, its Hydrochloride, and N,N-dialkyl Derivatives Against Non-albicans Candida Isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Clotrimazole; Diosgenin; Erythrocytes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Saponins | 2018 |
Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus niger; Clotrimazole; Female; Fluconazole; Fungal Proteins; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Nystatin; Otomycosis; Phylogeny; Polymerase Chain Reaction; Tubulin; Young Adult | 2018 |
[CASE REPORT OF CANDIDA PNEUMONIA].
Topics: Adolescent; Antifungal Agents; Candida albicans; Candidiasis; Delayed Diagnosis; Fluconazole; Humans; Kazakhstan; Male; Nystatin; Patient Readmission; Pneumonia; Practice Guidelines as Topic | 2018 |
Diversity, frequency and antifungal resistance of Candida species in patients with type 2 diabetes mellitus.
Topics: Adult; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis, Oral; Diabetes Mellitus, Type 2; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Nystatin | 2018 |
Gold Nanoparticles Conjugation Enhances Antiacanthamoebic Properties of Nystatin, Fluconazole and Amphotericin B.
Topics: Acanthamoeba castellanii; Amebicides; Amphotericin B; Cell Survival; Fluconazole; Gold; HeLa Cells; Humans; Metal Nanoparticles; Nanomedicine; Nystatin | 2019 |
Clinical Significance of the Floral Shift in Candidiasis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Fluconazole; Humans; Nystatin; Oils, Volatile; Voriconazole | 2018 |
Influence of subinhibitory antifungal concentrations on extracellular hydrolases and biofilm production by Candida albicans recovered from Egyptian patients.
Topics: Antifungal Agents; Aspartic Acid Proteases; Biofilms; Candida albicans; Egypt; Fluconazole; Fungal Proteins; Humans; Hydrolases; Micafungin; Microbial Sensitivity Tests; Nystatin; Phospholipases; Virulence Factors | 2019 |
Combination Therapy of Clinically Approved Antifungal Drugs Is Enhanced by Conjugation with Silver Nanoparticles.
Topics: Antifungal Agents; Aspergillus; Candida albicans; Drug Synergism; Fluconazole; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nystatin; Silver; Surface Properties | 2019 |
Study of the activity of Punica granatum-mediated silver nanoparticles against Candida albicans and Candida glabrata, alone or in combination with azoles or polyenes.
Topics: Amphotericin B; Antifungal Agents; Azoles; Biofilms; Candida albicans; Candida glabrata; Fluconazole; Metal Nanoparticles; Microbial Sensitivity Tests; Nystatin; Polyenes; Pomegranate; Silver | 2020 |
Amphotericin B, fluconazole, and nystatin as development inhibitors of Candida albicans biofilms on a dental prosthesis reline material: Analytical models in vitro.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Dental Prosthesis; Fluconazole; Nystatin | 2022 |
Consecutive treatments with photodynamic therapy and nystatin altered the expression of virulence and ergosterol biosynthesis genes of a fluconazole-resistant Candida albicans in vivo.
Topics: Animals; Antifungal Agents; Candida albicans; Ergosterol; Fluconazole; Mice; Nystatin; Photochemotherapy; Photosensitizing Agents; Virulence | 2021 |
Impact of Low-Dose Fluconazole on Tacrolimus Dosing in Renal Transplant.
Topics: Antifungal Agents; Azoles; Drug-Related Side Effects and Adverse Reactions; Fluconazole; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Nystatin; Retrospective Studies; Tacrolimus | 2022 |
Antifungal prescribing in neonates: Using national point prevalence survey data from Australia.
Topics: Animals; Antifungal Agents; Australia; Fluconazole; Nystatin; Prevalence | 2021 |
Origanum vulgare L. essential oil inhibits virulence patterns of Candida spp. and potentiates the effects of fluconazole and nystatin in vitro.
Topics: Candida; Fluconazole; Nystatin; Oils, Volatile; Origanum; Virulence | 2022 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Metabolite profiling, antifungal, biofilm formation prevention and disruption of mature biofilm activities of Erythrina senegalensis stem bark extract against Candida albicans and Candida glabrata.
Topics: Antifungal Agents; Biofilms; Candida; Candida albicans; Candida glabrata; Erythrina; Fluconazole; Nystatin; Plant Bark; Plant Extracts | 2022 |
Preparation, characterization and properties of three different nanomaterials either alone or loaded with nystatin or fluconazole antifungals.
Topics: Antifungal Agents; Chitosan; Fluconazole; Nanoparticles; Nanotubes, Carbon; Nystatin | 2022 |